Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0097 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 1 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3302 | 0.3302 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0097 | 1 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3302 | 0.3302 |
Giardia lamblia | Kinase, PLK | 0.0097 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 1 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3302 | 0.3302 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 1 | 0.5 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0097 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 1 | 0.5 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0097 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 1 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3302 | 0.3302 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0097 | 1 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0097 | 1 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0097 | 1 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0097 | 1 | 1 |
Trypanosoma brucei | polo-like protein kinase | 0.0097 | 1 | 0.5 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0097 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 1 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3302 | 0.3302 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.